Human health has been one of the first to benefit directly from biotechnological applications, from the production of antibiotics and other medicines in the middle of the last century to the present use of genetic engineering techniques, DNA reconstitution, Gene therapy, cloning, IVF (IVF) and microinjection. Tissues culture, Chimera, Stem cells, cryopreservation of cells, organs and embryos, establishment of Sperms Banks, laparoscopic surgery, laser therapy, and detection of potential serious diseases in the future by examining the map of the human genome and various other techniques, Treatment of some cases of infertility in humans or improvement of animal production or treatment of some genetic diseases and the production of many of the immunological and diagnostic preparations and medicines or innovative microprocessors.
The current development is not limited to the development of immunological, diagnostic and pharmacological compounds that were not previously available through genetic engineering methods, but rather to intensifying the productivity of known materials by carefully controlling the genetic structure of the cells and in the production process itself. Pharmaceutical companies have therefore begun to shift from drug discovery and development based on pharmaceutical chemistry to the design and development of information-based drugs provided by genes and related technologies. These products offer treatments for diseases not previously available. For example, insulin has become a possible treatment for diabetes through reprogrammed DNA technology as it has become a vaccine for hepatitis B disease. This is just the beginning of the science of biotechnology to develop better treatment and vaccines for HIV, malaria, cancer, heart disease and neurological disorders. Genetic therapy and countermeasures will also change the treatment of disease by treating symptoms.
These applications can be seen in two main sectors:
Diagnosis: The type of treatment depends on the type of treatment required and the diagnostic materials developed in the diagnosis of diseases such as genetic diseases and malignant diseases and diseases of microbial and parasitic diseases and dysfunction of some members.
II. Treatment: through the production of therapeutic materials such as antibiotics, immunological preparations, hormones and interferon, as well as through the treatment of human gene modification (gene therapy).
The current development is not limited to the development of immunological, diagnostic and pharmacological compounds that were not previously available through genetic engineering methods, but rather to intensifying the productivity of known materials by carefully controlling the genetic structure of the cells and in the production process itself. Pharmaceutical companies have therefore begun to shift from drug discovery and development based on pharmaceutical chemistry to the design and development of information-based drugs provided by genes and related technologies. These products offer treatments for diseases not previously available. For example, insulin has become a possible treatment for diabetes through reprogrammed DNA technology as it has become a vaccine for hepatitis B disease. This is just the beginning of the science of biotechnology to develop better treatment and vaccines for HIV, malaria, cancer, heart disease and neurological disorders. Genetic therapy and countermeasures will also change the treatment of disease by treating symptoms.
These applications can be seen in two main sectors:
Diagnosis: The type of treatment depends on the type of treatment required and the diagnostic materials developed in the diagnosis of diseases such as genetic diseases and malignant diseases and diseases of microbial and parasitic diseases and dysfunction of some members.
II. Treatment: through the production of therapeutic materials such as antibiotics, immunological preparations, hormones and interferon, as well as through the treatment of human gene modification (gene therapy).